Drug Trial Radar · NCT05531526
Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)
Last checked: Nov 19, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,535
Actual
Start
Dec 23, 2022
Primary completion
Jun 29, 2026
Study completion Oct 2027
Sponsor
- Lead sponsor
- AriBio Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Sep 8, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 55 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to evaluate the efficacy and safety of AR1001 for the treatment of participants with early AD.
Conditions
- Alzheimer Disease
Interventions
AR1001Drug
AR1001 Active Oral Tablet
PlaceboDrug
Placebo Oral Tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in the Clinical Dementia Rating Scale - Sum of Boxes (CDR-SB) (Overall Population)Time frame: Baseline to Week 52
- Change from Baseline in the Clinical Dementia Rating Scale - Sum of Boxes (CDR-SB) (Monotherapy Population)Time frame: Baseline to Week 52
Locations
198 sites in 13 countries. Site status is shown where the registry gives one.
IMA Clinical Research Phoenix
Phoenix, Arizona
Perseverance Research Center, LLC
Scottsdale, Arizona
Clinical Endpoints - N. Scottsdale
Scottsdale, Arizona
Banner Sun Health Research Institute
Sun City, Arizona
Voyage Medical
Tempe, Arizona
Sutter Health's Palo Alto Medical Foundation
Burlingame, California
Neuro-Pain Medical Center
Fresno, California
Fullerton Neurology and Headache Center
Fullerton, California
Esperanza Clinical
Murrieta, California
Valley Clinical Trials, INC
Northridge, California
Havana Research Institute
Pasadena, California
Kaizen Brain Center
San Diego, California
Adaptive Research
San Jose, California
The Neuron Clinic
San Marcos, California
Stanford Neuroscience Health Center
Stanford, California
Denver Neurological Research
Denver, Colorado
Mile High Research Center
Denver, Colorado
CenExel Rocky Mountain Clinical Research
Englewood, Colorado
Topaz Clinical Research
Apopka, Florida
BayCare Health System, Inc
Clearwater, Florida
Vertex Research Group
Clermont, Florida
Arrow Clinical Trial
Daytona Beach, Florida
Brainstorm Research - Loxahatchee
Loxahatchee Groves, Florida
ClinCloud LLC
Maitland, Florida
Verus Clinical Research, Corp
Miami, Florida
Vitae Research Center, LLC
Miami, Florida
Caro Medcenter and Community Research
Miami, Florida
Allied Biomedical Research Institute, Inc
Miami, Florida
Future Life Clinical Trials
Miami, Florida
Brainstorm Research
Miami, Florida
Meridian International Research, Inc
Miami Gardens, Florida
Charter Research - Orlando
Orlando, Florida
K2 Medical Research
Orlando, Florida
JEM Research Institute
Palm Beach, Florida
Progressive Medical Research
Port Orange, Florida
Angels Clinical Research Institute, Inc. - Tampa
Tampa, Florida
Charter Research - The Villages
The Villages, Florida
ClinCloud, LLC Melbourn
Viera, Florida
Conquest Research
Winter Park, Florida
iResearch -Atlanta
Atlanta, Georgia
Showing 40 of 198 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.